Clinical outcome of biomarker-guided therapies in adult patients with tumors of the nervous system

Abstract

Our study supports the clinical utility of biomarker-guided therapies for neuro-oncology patients and indicates clinical benefit in a subset of patients. Our data might inform future clinical trials, translational studies, and even clinical care.